Advik Laboratories Other Announcement
MPS Pharmaa Limited announced the availability of its FY 2025-26 Annual Report on its website. It also requested shareholders to update their KYC and PAN details.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
MPS Pharmaa Limited announced the availability of its FY 2025-26 Annual Report on its website. It also requested shareholders to update their KYC and PAN details.
Advik Laboratories Ltd filed its quarterly shareholding pattern as of June 30, 2026. The filing provides the distribution of shares among promoters and public shareholders.
MPS Pharmaa Limited filed its Annual Secretarial Compliance Report for the financial year ended March 2026. The report details governance compliance and historical listing fee defaults.
MPS Pharmaa Limited (formerly Advik Laboratories Limited) reported nil investor complaints for the quarter ended March 31, 2026. The company started, received, and disposed of zero complaints during the period, ending the quarter with no unresolved grievances.